These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15316891)

  • 1. [Specific immunotherapy in inhalative allergy to rat epithelium].
    Hansen I; Hörmann K; Klimek L
    Laryngorhinootologie; 2004 Aug; 83(8):512-5. PubMed ID: 15316891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Allergen-specific immunotherapy].
    Hansen TK; Svendsen UG
    Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergen immunotherapy: present and future.
    Finegold I
    Allergy Asthma Proc; 2007; 28(1):44-9. PubMed ID: 17390757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Respiratory allergies].
    Chiriac AM; Demoly P
    Presse Med; 2013 Apr; 42(4 Pt 1):395-404. PubMed ID: 22884514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific immunotherapy. Hyposensitization with allergens].
    Wedi B; Kapp A
    Hautarzt; 2004 Apr; 55(4):399-407; quiz 408-9. PubMed ID: 15146875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy.
    Ciprandi G; Tosca MA; Silvestri M
    Expert Rev Clin Immunol; 2014 Mar; 10(3):321-4. PubMed ID: 24450987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy].
    Scheinmann P; Pham Thi N; Karila C; de Blic J
    Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.
    CMAJ; 1995 May; 152(9):1413-9. PubMed ID: 7728690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic approaches in respiratory allergy are different depending on the profile of aeroallergen sensitisation.
    Domínguez-Ortega J; Quirce S; Delgado J; Dávila I; Martí-Guadaño E; Valero A
    Allergol Immunopathol (Madr); 2014; 42(1):11-8. PubMed ID: 23265263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O; Hörmann K; Klimek L
    MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen immunotherapy for respiratory allergic disease in Australia in 2016.
    Smith WB; Kette FE
    Med J Aust; 2017 Feb; 206(2):60-61. PubMed ID: 28152347
    [No Abstract]   [Full Text] [Related]  

  • 13. [Allergen-specific immunotherapy in pet allergy - an update].
    Raap U; Wagenmann M; Pfaar O
    Hautarzt; 2011 Sep; 62(9):657-62. PubMed ID: 21858563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local immunotherapy in chronic allergic rhinitis and bronchial asthma with allergen aerosols. III. Dynamics of some sensitization and immunity indexes.
    Moshkevich VS; Tsarevskaya LA; Nurpeisov TN; Nugmanova JS; Tsoy VP
    Allergol Immunopathol (Madr); 1986; 14(4):277-85. PubMed ID: 3776777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allergen-derived peptide: A promising approach in asthma].
    Klein M; Magnan A; Bouchaud G
    Rev Mal Respir; 2019 Apr; 36(4):442-446. PubMed ID: 31006580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma.
    Rossi RE; Monasterolo G
    Int J Immunopathol Pharmacol; 2005; 18(2):277-85. PubMed ID: 15888250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [House dust mite allergy].
    Urbanek R; Behrle M; Kuhn W
    Padiatr Padol; 1991; 26(1):25-30. PubMed ID: 2057207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy.
    Adamic K; Zidarn M; Bajrovic N; Erzen R; Kopac P; Music E
    Wien Klin Wochenschr; 2009; 121(9-10):357-60. PubMed ID: 19562302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical bystander effect exerted by allergen immunotherapy: a hypothesis.
    Ciprandi G
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):62-3. PubMed ID: 25781197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.